119 related articles for article (PubMed ID: 9681820)
21. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the EMS1 gene and its product, human Cortactin.
Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
24. Potential role of HOXD9 in synoviocyte proliferation.
Khoa ND; Nakazawa M; Hasunuma T; Nakajima T; Nakamura H; Kobata T; Nishioka K
Arthritis Rheum; 2001 May; 44(5):1013-21. PubMed ID: 11352232
[TBL] [Abstract][Full Text] [Related]
25. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification.
van Damme H; Brok H; Schuuring-Scholtes E; Schuuring E
J Biol Chem; 1997 Mar; 272(11):7374-80. PubMed ID: 9054437
[TBL] [Abstract][Full Text] [Related]
26. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
27. Activation of Arp2/3 complex-mediated actin polymerization by cortactin.
Uruno T; Liu J; Zhang P; Fan Yx ; Egile C; Li R; Mueller SC; Zhan X
Nat Cell Biol; 2001 Mar; 3(3):259-66. PubMed ID: 11231575
[TBL] [Abstract][Full Text] [Related]
28. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
29. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
30. Cortactin promotes cell motility by enhancing lamellipodial persistence.
Bryce NS; Clark ES; Leysath JL; Currie JD; Webb DJ; Weaver AM
Curr Biol; 2005 Jul; 15(14):1276-85. PubMed ID: 16051170
[TBL] [Abstract][Full Text] [Related]
31. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
[TBL] [Abstract][Full Text] [Related]
32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the functional domain requirements of cortactin in invadopodia formation.
Webb BA; Jia L; Eves R; Mak AS
Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
[TBL] [Abstract][Full Text] [Related]
34. [HS1 and EMS1].
He H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1448-53. PubMed ID: 9309140
[TBL] [Abstract][Full Text] [Related]
35. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
Schuuring E; Verhoeven E; Litvinov S; Michalides RJ
Mol Cell Biol; 1993 May; 13(5):2891-98. PubMed ID: 8474448
[TBL] [Abstract][Full Text] [Related]
36. Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells.
Fanciulli M; Paggi MG; Bruno T; Del Carlo C; Bonetto F; Gentile FP; Floridi A
Oncol Res; 1994; 6(9):405-9. PubMed ID: 7703526
[TBL] [Abstract][Full Text] [Related]
37. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin.
Campbell DH; Sutherland RL; Daly RJ
Cancer Res; 1999 Oct; 59(20):5376-85. PubMed ID: 10537323
[TBL] [Abstract][Full Text] [Related]
38. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines.
Campbell DH; deFazio A; Sutherland RL; Daly RJ
Int J Cancer; 1996 Nov; 68(4):485-92. PubMed ID: 8945620
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
[TBL] [Abstract][Full Text] [Related]
40. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells.
Hill A; McFarlane S; Mulligan K; Gillespie H; Draffin JE; Trimble A; Ouhtit A; Johnston PG; Harkin DP; McCormick D; Waugh DJ
Oncogene; 2006 Oct; 25(45):6079-91. PubMed ID: 16652145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
